Rallybio Corporation (RLYB) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Rallybio Corporation  (NASDAQ: RLYB)


Rallybio's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Rallybio's ROI in the second quarter of 2026?
Rallybio Corporation achieved a return on average invested assets (ROI) of 68.28 % in its second quarter of 2026 a new company high.

ROI has improved compared to -14.38% in the first quarter of 2026, due to net income growth.

Within the Healthcare sector 22 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 2813 to 3206.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM 14.67 % -18.56 % -26.8 % -35.09 % -41.77 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 95 50 58 63 46
Return On Investment (TTM) 68.28 % -14.38 % -16.23 % -25.19 % -71.59 %
RLYB's Overall Ranking # 3206 # 2813 # 2963 # 2935 # 3420
Seq. Investment Change TTM 22.71 % -1.69 % -1.7 % -3.3 % -12.85 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions 46 -8 -9 -14 -42

RLYB Company Profile >> Back to RLYB Roi Comparisons >> See Annual RLYB Return On Investment



Return On Investment RLYB's Ranking
Within: No.
Industry # 12
Sector # 23
Overall # 3206

Return On Investment Statistics
High Average Low
68.28 %
-44.2 %
-77.27 %
(Jun 30 2026)   (Sep 30 2024)



  News about Rallybio Corporation Return on Investment ROI

Rallybio Corporation Heralds Progress in Thrombosis Research Amid Financial Challenges

August 29, 2024

In the hallowed chambers of medical advancement, the Rallybio Corporation, a beacon within the ever-evolving landscape of biotechnology, unveiled a significant milestone befitting the relentless pursuit of alleviating human suffering from rare ailments. With headquarters nestled in the industrious borough of New Haven, Connecticut, this clinical-stage enterprise, known to the discerning circles of investors and scholars alike under the ticker symbol RLYB on the Nasdaq, recently announced the publication of its findings from a Phase 1 proof-of-concept study involving RLYB212 a novel monoclonal anti-HPA-1a antibody. This innovative therapeutic endeavor seeks to stave off maternal alloimmunization, a perilous condition that may lead to fetal and neonatal alloimmune thrombocytopenia (FNAIT), thus safeguarding the fragile lives of the next generation.The study s findings, now gracing the esteemed journal Thrombosis and Haemostasis , herald the dawn of a potential paradigm shift in the preventative approach towards FNAIT, an affliction that has long posed significant health risks to neonates. The enlightened research into RLYB212 exemplifies the application of scientific ingenuity intended to translate into the tangible betterment of human health a noble venture in a time beset by health inequities.





Financial Statements
Rallybio's II. Quarter Investments $ 95 Millions RLYB's Balance sheet
Rallybio's II. Quarter Income $ 44 Millions Quarterly RLYB's Income Statement
RLYB's Income by Division See RLYB's Income by Division


RLYB Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 58 62 106 170 176
Y / Y Investment Growth -6.19 % -41.83 % -37.32 % -3.38 % -
Net Income in Millions -9 -58 -75 -67 0
Y / Y Net Income Growth - - - - -
Annual Return On Investment -15.47 % -93.39 % -70.11 % -39.28 % 0 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
RLYB's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for RLYB's Competitors
Subscribers only: Roi for Rallybio's Suppliers
Subscribers only: Return On Investment for RLYB's Customers

Other Ratios
RLYB's Roa RLYB's Inventory Turnover Ratio RLYB's Growth Rates RLYB's Dividend Statistics
RLYB's Profitability Ratios RLYB's Asset Turnover Ratio RLYB's Dividend Growth
RLYB's Roe RLYB's Valuation Ratios RLYB's Financial Strength Ratios RLYB's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI
Sanuwave Health Inc   167.92 %
Vor Biopharma Inc   162.71 %
Capforce Inc   161.42 %
Kyntra Bio Inc   157.74 %
Silexion Therapeutics Corp  127.60 %
Quince Therapeutics Inc   112.49 %
Pulmatrix Inc   108.83 %
Interpace Biosciences Inc   100.71 %
Rigel Pharmaceuticals Inc  89.00 %
Oncotelic Therapeutics Inc   87.35 %
Arbutus Biopharma Corp  85.89 %
Actinium Pharmaceuticals Inc  84.38 %
Exelixis Inc   82.05 %
Lensar Inc   75.31 %
Ironwood Pharmaceuticals inc   70.54 %
Oramed Pharmaceuticals Inc  68.90 %
Indivior Pharmaceuticals Inc   68.79 %
Rallybio Corporation  68.28 %
Fortress Biotech Inc   68.27 %
Earth Science Tech Inc   64.38 %
Meiragtx Holdings Plc  55.83 %
Elite Pharmaceuticals Inc   53.48 %
Idexx Laboratories Inc  51.80 %
Aurinia Pharmaceuticals Inc   50.35 %
Qhslab Inc   48.94 %
Q32 Bio Inc   47.43 %
Vaxart Inc   46.17 %
Liquidia Corporation  42.09 %
Tg Therapeutics Inc   39.26 %
Medpace Holdings Inc   35.54 %

Date modified: 2026-09-08T22:05:12+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.